CAR T Cell Therapy Market is Speeding to Consume a Phenomenal Double-Digit CAGR of 58.82%
Market Highlights: The Global CAR T Cell Therapy Market is expected to register a CAGR of 58.52% during the forecast period, with a market value of USD 346.75 Million in 2018. Chimeric Antigen Receptor (CAR) T Cell Therapy is an immunotherapy used for cancer treatment. In this therapy, T cells from patient body are isolated and inserted in the CAR gene so that the gene for the specific receptor binds to a certain protein on the patient’s cancer cells. Growing prevalence of cancer across the world, technological advancement for advanced & reliable treatment for cancer, and rise in the number of cell therapy clinical studies are driving the growth of the global CAR T Cell Therapy market. According to the National Cancer Institute, it is estimated that 1,735,350 new cases of cancer were diagnosed, and 609,640 deaths were reported in the US in 2018. Moreover, the growing pharmaceutical industry is also expected to boost market growth. ...